Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Latest Articles
280
Views
0
CrossRef citations to date
0
Altmetric
Research Article

HIV associated neurocognitive disorder screening and diagnosis pathways in Australia: a scoping review and international implications

, , , , , , , & show all
Received 09 May 2023, Accepted 10 Apr 2024, Published online: 29 Apr 2024

References

  • Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., Gisslen, M., Grant, I., Heaton, R. K., Joseph, J., Marder, K., Marra, C. M., McArthur, J. C., Nunn, M., Price, R. W., Pulliam, L., … Wojna, V. E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799. https://doi.org/10.1212/01.WNL.0000287431.88658.8b
  • Aung, H. L., Siefried, K. J., Gates, T. M., Brew, B. J., Mao, L., Carr, A., & Cysique, L. A. (2023). Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not. eClinicalMedicine, 56, 101792. https://doi.org/10.1016/j.eclinm.2022.101792
  • Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine. (2022). Standards for Psychological Support for Adults with HIV. Retrieved December 16, 2022, from https://www.ashm.org.au/resources/australian-standards-for-psychological-support-for-adults-with-hiv/
  • Australian Federation of AIDS Organisations; National Association of People with HIV Australia. (2015). Living well: Women with HIV: Information about some of the key issues for women with HIV. https://tinyurl.com/4hfteet7
  • Australian Government Department of Health. (2018). Eighth National HIV Strategy. https://tinyurl.com/4pnwtdb2
  • Bloch, M., Kamminga, J., Jayewardene, A., Bailey, M., Carberry, A., Vincent, T., Quan, D., Maruff, P., Brew, B., & Cysique, L. A. (2016). A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review. Clinical Infectious Diseases, 63(5), 687–693. https://doi.org/10.1093/cid/ciw399
  • Bougea, A., Spantideas, N., Galanis, P., Gkekas, G., & Thomaides, T. (2019). Optimal treatment of HIV-associated neurocognitive disorders: Myths and reality. A critical review. Therapeutic Advances in Infectious Disease, 6. https://doi.org/10.1177/2049936119838228
  • Brew, B., Cummins, D., & Crawford, D. (2016a). HIV associated neurocognitive disorder. Positive Life NSW. https://tinyurl.com/389vbc9a
  • Brew, B., Cummins, D., & Crawford, D. (2016b). HIV associated neurocognitive disorder. Positive Life NSW. Partners, Family, friends and carers of people with HIV associated neurocognitive disorder. Positive Life NSW. https://tinyurl.com/23at3z3z
  • Crawford, D. (2016, December 18). Lets talk about hand. Blog. https://www.positivelife.org.au/blog/talk-about-hand/
  • Crawford, D. (2017, March 14). The good news about HAND. Blog. https://www.positivelife.org.au/blog/good-news-about-hand/
  • Cummins, D. (2019). HIV-associated neurocognitive disorder. https://hivmanagement.ashm.org.au/hiv-associated-neurocognitive-disorder/
  • Cummins, D., Murray, K., Trotter, G., Batterham, M., Healey, L. & O’Connor, C. (2017), Can patients and their caregivers boost identification of HIV Associated Neurocognitive Disorder (HAND)? Australian Journal of Advanced Nursing, 34(3), 24–33. https://www.ajan.com.au
  • Cummins, D., Waters, D., Aggar, C., & O'Connor, C. C. (2018). Potential impacts of poor communication on early diagnosis of HIV-associated neurocognitive disorder. Journal of Advanced Nursing, 74(6), 1342–1348. https://doi.org/10.1111/jan.13533
  • Cummins, D., Waters, D., Aggar, C., & O’Connor, C. C. (2019). Assessing risk of HIV-associated neurocognitive disorder. Nursing Research, 68(1), 22–28. https://doi.org/10.1097/NNR.0000000000000312
  • Cysique, L., Bain, M. P., Lane, T. A., & Brew, B. (2012). Management issues in HIV-associated neurocognitive disorders. Neurobehavioral HIV Medicine, 4, 63–73. https://doi.org/10.2147/NBHIV.S30466
  • Cysique, L. A., & Brew, B. J. (2009). The assessment of HIV-associated neurocognitive disorders: New challenges in the HAART era. In R. P. Sacktor, V. Valcour, & K. Tashima (Eds.), HIV and the brain: New challenges in the modern era (1st ed., pp. 109–132). Humana Press Inc. https://doi.org/10.1007/978-1-59745-434-6_7
  • Cysique, L. A., Brew, B. J., Bruning, J., Byrd, D., Costello, J., Daken, K., Ellis, R. J., Fazeli, P. L., Goodkin, K., Gouse, H., Heaton, R. K., Letendre, S., Levin, J., Aung, H. L., Mindt, M. R., Moore, D., Mullens, A. B., de Almeida, S. M., Muñoz–Moreno, J. A., … Rourke, S. B. (2024). Cognitive criteria in HIV: Greater consensus is needed. Nature Reviews Neurology, 20(2), 127–128.
  • Cysique, L. A., Maruff, P., Darby, D., & Brew, B. J. (2006). The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Archives of Clinical Neuropsychology, 21(2), 185–194. https://doi.org/10.1016/j.acn.2005.07.011
  • Dementia Australia. (2014a). Living with HIV-associated neurocognitive disorders (HAND): Information for people living with HIV and HAND, their partners, Families, and friends. https://www.dementia.org.au/sites/default/files/HAND-booklet-for-consumers.pdf
  • Dementia Australia. (2014b). HIV-associated neurocognitive disorders (HAND): A toolkit for community care workers. https://tinyurl.com/5n8ac296
  • Dementia Australia. (n.d.). HIV associated dementia. From About dementia Series no 19. https://tinyurl.com/4kzwmvav
  • Gates, T. M., Kamminga, J., Jayewardene, A., Vincent, T., Quan, D., Brew, B. J., Bloch, M., & Cysique, L. A. (2021). An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications. Archives of Clinical Neuropsychology, 36(4), 597–612. https://doi.org/10.1093/arclin/acaa076
  • Haddaway, N. R., Pritchard, C. C., & McGuinness, L. A. (2021). PRISMA2020: R package and ShinyApp for producing PRISMA 2020 compliant flow diagrams (Version 0.0.2). Zendodo. https://doi.org/10.5281/zenodo.4287834
  • Heaton, R. K., Ellis, R. J., Tang, B., Marra, C. M., Rubin, L. H., Clifford, D. B., McCutchan, J. A., Gelman, B. B., Morgello, S., Franklin, D. R., & Letendre, S. L. (2023). Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: A CHARTER study. Brain, 146(3), 1121–1131. https://doi.org/10.1093/brain/awac465
  • Herrmann, S., McKinnon, E., Skinner, M., Duracinsky, M., Chaney, R., Locke, V., & Mastaglia, F. (2019). Screening for HIV-Associated neurocognitive impairment: Relevance of psychological factors and era of commencement of antiretroviral therapy. Journal of the Association of Nurses in AIDS Care, 30(1), 42–50. https://doi.org/10.1097/JNC.0000000000000040
  • Ian, E., Gwen, C. L., Soo, C. T., Melissa, C., Chun-Kai, H., Eosu, K., Hyo-Youl, K., Asad, K., Scott, L., Chung-Ki, L. P., Anekthananon, T., Jordan, T. G., Han-Ting, W., & Wing-Wai, W. (2016). The burden of HIV-associated neurocognitive disorder (HAND) in the Asia-Pacific region and recommendations for screening. Asian Journal of Psychiatry, 22, 182–189. https://doi.org/10.1016/j.ajp.2015.10.009
  • Kamminga, J., Bloch, M., Vincent, T., Carberry, A., Brew, B. J., & Cysique, L. A. (2017). Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. Journal of Clinical and Experimental Neuropsychology, 39(8), 753–767. https://doi.org/10.1080/13803395.2016.1263282
  • Kamminga, J., Lal, L., Wright, E., Bloch, M., Brew, B., & Cysique, L. (2017). Monitoring HIV-associated neurocognitive disorder using screenings: A critical review including guidelines for clinical and research use. Current HIV/AIDS Reports, 14(3), 83–92. https://doi.org/10.1007/s11904-017-0349-9
  • Kinai, E., Komatsu, K., Sakamoto, M., Taniguchi, T., Nakao, A., Igari, H., Takada, K., Watanabe, A., Takahashi-Nakazato, A., Takano, M., Kikuchi, Y., & Oka, S. (2017). Association of age and time of disease with HIV-associated neurocognitive disorders: A Japanese nationwide multicenter study. Journal of NeuroVirology, 23(6), 864–874. https://doi.org/10.1007/s13365-017-0580-6
  • Kwasa, J., Cettomai, D., Lwanya, E., Osiemo, D., Oyaro, P., Birbeck, G. L., Price, R. W., Bukusi, E. A., Cohen, C. R., & Meyer, A. L. (2012). Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: Pilot testing in Kenya. PLoS ONE, 7(3), e32898. https://doi.org/10.1371/journal.pone.0032898
  • Manning, V., Gooden, J. R., Cox, C., Petersen, V., Whelan, D., & Mroz, K. (2021). Managing cognitive impairment in AOD treatment: Practice guidelines for healthcare professionals. Turning Point.
  • Mapstone, M., Hilton, T. N., Yang, H., Guido, J. J., Luque, A. E., Hall, W. J., Dewhurst, S., & Shah, K. (2013). Poor aerobic fitness may contribute to cognitive decline in HIV-infected older adults. Aging and Disease, 4(6), 311–319. https://doi.org/10.14336/AD.2013.0400311
  • Murray, K. J., Cummins, D., Batterham, M., Trotter, G., Healey, L., & O'Connor, C. C. (2016). Does the informal caregiver notice HIV associated mild cognitive impairment in people living with HIV? AIDS Care, 28(2), 221–227. https://doi.org/10.1080/09540121.2015.1084989
  • Musso, M. W., Cosgrove, S. J., Peltier, M. R., McGee, B. L., & Jones, G. N. (2018). Problems screening for HAND among the educationally disadvantaged. Applied Neuropsychology: Adult, 25(2), 120–125. https://doi.org/10.1080/23279095.2016.1248766
  • Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
  • Neuropsychology.org. (n.d.). Neuropsychology. Retrieved December 16, 2022, from http://www.neuropsychology.org.au/
  • Nightingale, S., Ances, B., Cinque, P., Dravid, A., Dreyer, A. J., Gisslén, M., Joska, J. A., Kwasa, J., Meyer, A. C., Mpongo, N., & Winston, A. (2023). Cognitive impairment in people living with HIV: Consensus recommendations for a new approach. Nature Reviews Neurology, 19(7), 424–433. https://doi.org/10.1038/s41582-023-00813-2
  • Nightingale, S., Cinque, P., Dravid, A., Dreyer, A. J., Gisslén, M., Joska, J. A., Kwasa, J., Meyer, A., Mpongo, N., Nakasujja, N., Pebody, R., Pozniak, A., Price, R. W., Saylor, D., Thomas, K. G. F., Underwood, J., Vera, J. H., & Winston, A. (2024). Reply to ‘Cognitive criteria in HIV: Greater consensus is needed’. Nature Reviews Neurology, 20(2), 129–130. https://doi.org/10.1038/s41582-024-00928-0
  • Obermeit, L., Beltran, J. Casaletto, K., Franklin, D., Letendre, S., Ellis, R., Fennema-Notestine, C., Vaida, F., Collier, A., Marra, C., Clifford, D., Gelman, B., Sacktor, N., Morgello, S., Simpson, D., McCutchan, J., Grant, I., & Heaton, R. (2017). Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): Defining “symptomatic” versus “asymptomatic” HAND. Journal of NeuroVirology, 23(1), 67–78. https://doi.org/10.1007/s13365-016-0474-z
  • Parry, S., Zetler, S., Kentridge, A., Petrak, J., & Barber, T. (2017). Simple screening for neurocognitive impairment in routine HIV outpatient care: Is it deliverable? AIDS Care, 29(10), 1275–1279. https://doi.org/10.1080/09540121.2017.1300632
  • Peters, M. D., Godfrey, C. M., McInernery, P., Soares, C. B., Khalil, H., & Parker, D. (2015). The Joanna Briggs Institute reviewers’ manual 2015: Methodology for JBI Scoping reviews. The Joanna Briggs Institute.
  • Peters, M. D., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., McInerney, P., Godfrey, C. M., & Khalil, H. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis, 18(10), 2119–2126. https://doi.org/10.11124/JBIES-20-00167
  • Queensland Positive People (QPP). (2022). HIV-associated neurological disorders. Retrieved December 16, 2022, from https://www.qpp.org.au/hiv-associated-mnd-mild-neurocognitive-disorder/
  • Sacktor, N., Skolasky, R. L., Seaberg, E., Munro, C., Becker, J. T., Martin, E., Ragin, A., Levine, A., & Miller, E. (2016). Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology, 86(4), 334–340. https://doi.org/10.1212/WNL.0000000000002277
  • Sinclair, J. (2023, August 28). Australian R&D spending drops as percentage of GDP. https://www.researchprofessionalnews.com/rr-news-australia-politics-2023-8-australian-r-d-spending-drops-as-percentage-of-gdp/
  • Tedaldi, E. M., Minniti, N. L., & Fischer, T. (2015). HIV-associated neurocognitive disorders: The relationship of HIV infection with physical and social comorbidities. Biomed Research International, 2015, 641913. https://doi.org/10.1155/2015/641913
  • The Kirby Institute. (2023). HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2023.
  • Thompson, F., Cysique, L. A., Harriss, L. R., Taylor, S., Savage, G., Maruff, P., & McDermott, R. (2020). Acceptability and usability of computerized cognitive assessment among Australian indigenous residents of the Torres Strait Islands. Archives of Clinical Neuropsychology, 35(8), 1288–1302. https://doi.org/10.1093/arclin/acaa037
  • Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., … Straus, S. E. (2018). PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467–473. https://doi.org/10.7326/M18-0850
  • Underwood, J., & Winston, A. (2016). Guidelines for evaluation and management of cognitive disorders in HIV-positive individuals. Current HIV/AIDS Reports, 13(3), 235–240. https://doi.org/10.1007/s11904-016-0324-x
  • Wang, Y., Liu, M., Lu, Q., Farrell, M., Lappin, J. M., Shi, J., Lu, L., & Bao, Y. (2020). Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis. Neurology, 95(19), e2610–e2621. https://doi.org/10.1212/WNL.0000000000010752
  • Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x